Skip to main content
Yifeng Pharmacy Chain Co., Ltd. logo

Yifeng Pharmacy Chain Co., Ltd. — Investor Relations & Filings

Ticker · 603939 ISIN · CNE100001TS5 LEI · 300300CZZIF44N1EZO06 Shanghai Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,865 across all filing types
Latest filing 2025-08-25 Board/Management Inform…
Country CN China
Listing Shanghai Stock Exchange 603939

About Yifeng Pharmacy Chain Co., Ltd.

https://www.yfdyf.cn/

Yifeng Pharmacy Chain Co., Ltd. operates as a large-scale retail pharmacy enterprise. The company specializes in the distribution and sale of prescription drugs, over-the-counter medicines, traditional Chinese medicine, nutritional supplements, and medical devices. It utilizes a standardized management system across its extensive network of retail stores to ensure service quality and operational efficiency. Beyond physical retail, the company has developed a comprehensive digital healthcare ecosystem, integrating online-to-offline (O2O) services to provide professional pharmaceutical consultations and health management solutions. Its business model focuses on a "big health" strategy, aiming to provide accessible healthcare products and professional services to a broad consumer base through optimized supply chain logistics and a diversified product portfolio.

Recent filings

Filing Released Lang Actions
益丰药房关于公司高级管理人员离任的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the resignation of a senior management member, specifically the vice president of the company. It details the departure date, reason for leaving, and confirms that the departure will not affect normal operations. There is no financial data, no mention of a report or meeting, and the content focuses solely on management personnel changes. This fits the definition of 'Board/Management Information' (MANG). The document length is short and it is not a report publication or certification. Therefore, the classification is MANG with high confidence.
2025-08-25 Chinese
益丰药房关于选举职工董事的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the election of an employee representative director to the company's board. It includes details about the election process, the qualifications of the elected director, and compliance with relevant laws and regulations. There is no financial data, report, or presentation content. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2025-08-25 Chinese
益丰药房2025年第二次临时股东会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a detailed announcement of the resolutions passed at the 2025 second extraordinary shareholders meeting of Yifeng Pharmacy Chain Co., Ltd. It includes information about the meeting date, location, attendance, voting results on various proposals, and legal witness statements. The content focuses on shareholder meeting decisions and voting outcomes rather than financial results or management changes. It is not an annual or interim report, earnings release, or management discussion. The document is a formal announcement of voting results from a shareholders meeting, which fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is 3203 characters, which is consistent with a detailed voting results announcement rather than a full report or presentation.
2025-08-25 Chinese
湖南启元律师事务所关于益丰大药房连锁股份有限公司2025年第二次临时股东会的法律意见书
Regulatory Filings
2025-08-25 Chinese
益丰药房2025年第二次临时股东会会议资料
AGM Information Classification · 100% confidence The document is titled "2025 年第二次临时股东会会议资料" which translates to "2025 Second Extraordinary General Meeting (EGM) Materials". It contains detailed meeting agenda, voting proposals, and amendments to company bylaws and governance documents. The content includes multiple proposals to be voted on by shareholders, such as amendments to the Articles of Association, board rules, and other governance-related policies. The document is 15,000 characters long, indicating it is a full set of meeting materials rather than a brief announcement. The nature of the document is clearly related to shareholder meeting materials, specifically for an extraordinary general meeting, which fits the category of AGM Information (AGM-R). It is not a voting results announcement (DVA) because it contains the meeting agenda and proposals, not the results. It is not a proxy solicitation (PSI) because it is the meeting materials themselves. Therefore, the correct classification is AGM Information (AGM-R).
2025-08-19 Chinese
益丰药房第五届监事会第十四次会议决议公告
Board/Management Information Classification · 95% confidence The document is a resolution announcement from the Supervisory Board (监事会) of 益丰大药房连锁股份有限公司 regarding the 14th meeting of the 5th Supervisory Board. It includes details about the meeting date, attendance, voting results, and specific agenda items such as waiving the notice period and providing guarantees for a subsidiary's bank credit application. The document is short (1000 characters) and is an official announcement of meeting resolutions rather than a full report or financial statement. It does not contain financial data, audit information, or detailed management discussion. It is not a call transcript, earnings release, or capital update. It is a formal announcement of board/management decisions related to governance and supervisory board activities. Therefore, the best fitting category is Board/Management Information (MANG).
2025-08-14 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.